Best Paul Schrimpf Podcasts (2025)

1
Paul Schrimpf, Proprietor and Entrepreneur at Cyrall 37:00

Play Pause

1M ago37:00

37:00

In this episode of Talk Radioisotopes, Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and leadership roles advising top healthcare organizations, Paul draws on deep experience across strategy, marketing, and team developmen…

1
Building a Smarter Radiopharma Future with AI-Driven Drug Discovery 21:22

2M ago21:22

21:22

In this episode of Talk Radioisotopes, host Scott Ravi sits down with Sigal Kalmanson Cusnir, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and developed by merging AI technology with decades of expertise in peptide chemistry. Si…

1
The Goldilocks Isotope? Why Astatine-211 Might Be Just Right for Radiotherapeutics 36:22

3M ago36:22

36:22

In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling of astatine-based compounds. Milton explains how the company's roots in the Unive…

1
Luke Nordquist, CEO of XCancer 38:17

3M ago38:17

38:17

In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate cancer trials to community care settings—and how it has grown into a nationwide cli…

1
Matt Furlow, Principal Associate at ZS 31:46

4M ago31:46

31:46

On this episode, hosts Scott and Sarah are joined by Matt Furlow, Associate Principal at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering and a decade of consulting experience, Matt brings a unique perspective on how scientific insight and strategic planning intersect to help biotech and pharma companies…

1
Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham 31:14

4M ago31:14

31:14

On this episode, hosts Scott and Sarah sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi’s multifaceted role in radiopharmaceutical research, isotope production, and academic training. She shares how her team at UAB de…

1
[OpEd: MicroD goes Macro] Postface 17:20

4M ago17:20

17:20

There were some open ends in my last episode that we wanted to come back to, provide closure, as well as some more perspectives and opinions.

1
Shamar Young, Chief Medical Officer at TeleDaaS 31:38

5M ago31:38

31:38

On this episode of Talk Radioisotopes, Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into interventional radiology, his expertise in Yttrium-90 (Y90) therapy, and the evolving role of precision…

1
Bruno Paquin, CEO of AtomVie Global Radiopharma 40:57

5M ago40:57

40:57

In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract development and manufacturing organization (CDMO), their cutting-edge work in ca…

1
Arjun Murthy, Co-Founder of Maven Bio 31:51

5M ago31:51

31:51

On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, along with Maven Bio's technology, is transforming data analysis and research in the biopharma sector. Key topics include how AI is a…

1
[OpEd: MicroD goes Macro] Closing Thoughts - It's All a Trick 21:57

6M ago21:57

21:57

We wrap our latest series on macro-issues facing healthcare with a look back on the series. It intersects with a timely personal story that highlights how upside down our system is and the reasons behind it. In the process, I credit my wife with summarizing it all: "The US Healthcare System just feels like it's one giant trick being played on us al…

1
Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals 45:17

6M ago45:17

45:17

On this episode, hosts Scott and Sarah sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's innovations, and breakthroughs involving copper-based compounds for cancer treatment. Shaemus shares insights on the importance of …

1
Jeff Jones, Managing Director, Senior Analyst at Oppenheimer & Company 36:37

6M ago36:37

36:37

On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,' host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company. The discussion covers the latest trends in the radiopharmaceutical and radiotherapeutics markets, including the rise of targeted radiotherapies, the involvement of large pha…

1
[OpEd: MicroD goes Macro] Value Based Care Myths 16:58

7M ago16:58

16:58

The value-based care (VBC) philosophy is centered around improving patient outcomes while reducing costs by rewarding providers for quality over quantity of services. But in reality, it's just this era's term for cost containment and restricted care. And don't get us started on Medicare Advantage VBC programs and how they approach end-of-life care.…

1
[OpEd: MicroD goes Macro] Other Countries and Government Provided Care 14:45

7M ago14:45

14:45

In this episode, we explore the unique economic model of U.S. healthcare, contrasting its privatized structure with the government-provided systems of other developed countries. We examine the high costs, inconsistent outcomes, and cultural dynamics that make U.S. healthcare highly unique compared to nearly 200 other countries. The US ranks #1 on o…

1
[OpEd: MicroD goes Macro] Where the Customers Are 6:09

8M ago6:09

6:09

In Maurice Sendak’s book, Where the Wild Things are, a boynamed Max finds himself in an exotic world of the Wild Things. In the world of healthcare, understanding “wherethe customers are” can often seem equally exotic and hard to understand. We’ll touch upon that in this episode.

1
[OpEd: MicroD goes Macro] The Myth of Healthcare Consumerism 7:56

8M ago7:56

7:56

There are so many healthcare organizations that say, "It's all about the patient." The reality it's not. And never has been. Yes, the core KPI is patient outcomes, but don't think for a second the patient is the customer. In a number of instances, they are, but in most instances they are not. And we'll explain more in this episode.…

1
[OpEd: MicroD goes Macro] Insurance That's Not Really Insurance 7:41

8M ago7:41

7:41

In this episode, we’ll talk about how US health insurance isn’t really insurance, and how the US healthcare system -which is largely private- is still heavily influenced by the government. Begging the question: How private and capitalistic is our healthcare system, and are we really gaining anything compared to other government-run systems?…

1
Trailer - Talk Radioisotopes: Going Nuclear on Cancer 1:16

8M ago1:16

1:16

Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear o…

1
[OpEd: MicroD goes Macro] Intro 5:31

8M ago5:31

5:31

In this series, Microdosing goes Marco. We'll be talking about economic models, who actually pays for healthcare in the US, who's in control, and what it all means. We'll raise more questions than we'll answer, but understanding these macro forces are important in making successful tactical decisions.…

1
[Bookmark] 100 Episides and Swag! 1:48

1y ago1:48

1:48

Microdosing isn't a 52-week podcast. We take breaks. We're taking one now and will get back to you after the summer. If you want some Microdosing swag, leave a review wherever you consume podcasts, and email Paul a screen grab. Or DM him on LinkedIn: https://www.linkedin.com/in/schrimpf/ (www.md-pod.com also works)…

1
[Series: Product Management] Closing Thoughts 15:23

1y ago15:23

15:23

We interviewed a group of terrific product leaders during this time. Looking back, here are a few of our observations.

1
[Series: Product Management] Alex Moseman 22:59

1+ y ago22:59

22:59

Product Management guru and wannabe Premier League goalie, Alex Moseman, joins us for this episode. He talks about his experience leading product efforts in medical devices, healthcare services, and various other industries.

1
[Series: Product Management] Jo Roberts 18:12

1+ y ago18:12

18:12

From Apple, to designing the patient experience in medsurge wings, to now leading Business Design efforts at Prophet, Jo brings an incredibly robust view to product management and value creation for both the customer/user and the business.

1
[Series: Product Management] Jitin Asnaani 21:39

1+ y ago21:39

21:39

Jitin Asnaani, Chief Product Officer of Rhapsody, joins us in this episode where we talk about the different ways to talk about the productization of data, interpretability, and [fill in the blank] as a service.

1
[Series: Product Management] Stephanie Rock 16:59

1+ y ago16:59

16:59

Stephanie Rock of Intus Care joins us in this episode, and talks about how value based care needs to be managed in its totality. It's not just plan design. It's not just a care delivery model. Everything needs to be factored into it, as all of it affects outcomes.

1
[Series: Product Management] Robert Laumeyer 21:29

1+ y ago21:29

21:29

Robert Laumeyer of Availity joins us in this episode, bringing his experience in tech, his patterns that have contributed to product experiences at Google, Microsoft, and HP. We talk about the importance of communication in product management and the great work he's doing at Availity to address problems with pre-authorization.…

1
[Series: Product Management] Sarah Reilly 19:44

1+ y ago19:44

19:44

Sarah Reilly of Lucet talks about the importance of bringing a blended product management approach to both tech and service elements of an experience. Arguing to include the environment in which your product is deployed should be factored into your overall product design and management approach.

1
[Series: Product Management] Marina Simonian 17:53

1+ y ago17:53

17:53

In this episode, Marina Simonian of Uptiv Health talks about how she brings her background in psychology -and finding ways to make things happen with whatever you have on hand- to her role as Product Lead and Founder at Uptiv Health.

1
[Series: Product Management] Megha Kadiyala 16:55

1+ y ago16:55

16:55

Med student -turned- consultant -turned- strategist -turned- product executive, Megha Kadiyala joins us on this episode to share her perspectives on Product Management and user flows in today's pharmacy space.

1
[Series: Product Management] Alex Hoopes 24:56

1+ y ago24:56

24:56

Self-proclaimed misfit clinician, Alex Hoopes, joins us inthis episode to discuss his vides and philosophies on product development, and the latest reconning for greater pragmatism, and not just asking product leaders to own innovation, but be accountable for driving value.

1
[Series: Product Management] Alice McNeil 17:29

1+ y ago17:29

17:29

From some of the smallest, fastest-growing healthcare companies to literally the biggest of the bigs, Alice McNeil's career has spanned nearly every function of the organization, and she brings a very unique and powerful perspective to the world of Products.

1
[Series: Product Management] Kord Brashear 19:57

1+ y ago19:57

19:57

Kord Brasher sits down in this episodes and shares his experience working at places such as UnitedHealth Group, EPAM Continuum, Catapult Thinking, and now Compeer Financial.

1
[Series: Product Management] Brandon Fiegoli 17:41

1+ y ago17:41

17:41

Brandon Fiegoli of Farbric joins us for this episode andshares his philosophies and best practices that he’s picked up throughout hiscareer which includes IBM and Butterfly Network. He also talks about why it’s important toalways as ASK MORE QUESTIONS!

1
[Series: Product Management] Opening Thoughts 8:02

1+ y ago8:02

8:02

Product Management (and the variety of overlapping functions of R&D, Innovation, and Product Development) is a fast-growing sector, yet many Healthcare companies appear to be deficient in its basic core tenets. In this series, we do a deep dive into all things product, and Paul shares his perspective in this opening episode.…

1
[Series: Meet Paul's Colleagues] Jeff Gourdji 9:40

2y ago9:40

9:40

The series wouldn't be complete without a conversation with my good friend Jeff Gourdji. He sits down to talk about healthcare policy, midwest healthcare innovation, and the University of Michigan Wolverines.

1
[Series: Meet Paul's Colleagues] Adrienne Albright 13:53

2y ago13:53

13:53

Adrienne Albright sits down and discusses bloodletting and other things related to medieval science on this episode of Microdosiong.

1
[Series: Meet Paul's Colleagues] Nicole Diamant 12:57

2y ago12:57

12:57

On this episode, Nicole Diamant not only shares great perspectives into the work at Prophet, but she also provides some great career advice overall.

1
[Series: Meet Paul's Colleagues] Tanisha Shah 11:37

2y ago11:37

11:37

Tanisha Shah joins us in this episode. With a background in digital commerce, business analytics, and studying abroad, she brings a very unique set of perspectives and skills focused on the importance of putting consumers at the center of healthcare.

1
[Series: Meet Paul's Colleagues] Ellie Winslow 12:50

2y ago12:50

12:50

Meet another fantastic member of Prophet's healthcare team: Ellie Winslow. A lot of people say they are fast learners, but Ellie takes it to another level. The speed in which she gets up to speed on almost anything (oftentimes on her own for better or worse) is mind-boggling.

1
[Series: Meet Paul's Colleagues] Alisha Shah 13:48

2y ago13:48

13:48

We all wear many hats at Prophet, and Alisha Shah wearsseveral. She kicks off our series,centered around Paul’s coworkers at Prophet and the work they do. Alisha shares her perspectives on alwaysbringing a perspective and balancing strategy, rigor, and creativity.

1
[Labor Crisis Series] Co-Hosts Geoffrey and Paul's Closing Thoughts 24:06

2y ago24:06

24:06

There were so many terrific conversations with Paul and Geoffrey throughout the Labor Crisis Series. It was impossible to know where to begin or end. That said, here are their highlights and take aways.

1
[Labor Crisis Series] Danielle McCamey, CEO of DNPs of Color 14:57

2+ y ago14:57

14:57

Danielle McCamey, DNP, ACNP-BC, FCCP, CEO of DNPs of Color, and Assistant Dean at Johns Hopkins School of Nursing, talks about creating inclusive spaces for today's modern healthcare workforce, and the importance of pulling more nurses up into overall leadership roles of healthcare organizations.

1
[Labor Crisis Series] Dan Weberg of Ohio State University 20:49

2+ y ago20:49

20:49

Dr. Dan Weberg, PhD, MHI, RN, FAAN talks about the gap in healthcare innovation between technology designed for nurses that lacks nurse input, as well as scaling challenges around service-line-based business models.

1
[Labor Crisis Series] Whitney Staub-Juergens of HCA Healthcare 20:58

2+ y ago20:58

20:58

Whitney Staub-Juergens DNP-HSL, MSN, RN, CCRN-K, NE-BC is the Vice President of Clinical Transformation and Innovation at HCA Healthcare. She talks about how today's hospitals have technical infrastructures that are struggling to keep up with today's care needs. And that some of these tech and digital gaps have created extra work via "human patches…

1
[Labor Crisis Series] Heidi Chumley of Ross University School of Medicine 19:20

2+ y ago19:20

19:20

Dr. Heidi Chumley, Dean of Ross University School of Medicine talks about "social determinants of learning" as it relates to clinical education, and how we need to rethink the pipeline of the next-generation doctors and nurses; where we are sourcing students and educating a more diverse clinical workforce of the future.…

1
[Labor Crisis Series] Jeff Terry of GE Healthcare Command Centers 22:52

2+ y ago22:52

22:52

Jeff Terry, CEO of GE Healthcare Command Centers, talks about how their technology -and others like it- is dramatically reducing the amount of time care teams need to identify, understand, and act on a variety of care delivery needs.

1
[Labor Crisis Series] Syl Trepanier of Providence Health 19:20

2+ y ago19:20

19:20

Dr. Syl Trepanier, SVP, System Chief Nursing Officer of Providence Health talks about the need to rethink care team, and the challenges associated with getting people comfortable with "not doing" things they have gotten used to doing, as we look to deploy new care models, and have new roles for clinicians and non-clinicians to play.…

1
[Labor Crisis Series] Marcus Osbourne of RightMove Health 20:50

2+ y ago20:50

20:50

Former Sr Vice President of Walmart Health and current CEO of RightMove Health, Marcus Osbourne, sits down with us and discusses limitations in today's standard care teams, and talks about the importance of workforce and business model innovation as it relates to addressing the clinical labor crisis.…

1
[Labor Crisis Series] Jan Jones-Schenk of Western Governors University 17:02

2+ y ago17:02

17:02

Jan Jones-Schenk, Executive Dean Emeritus of Western Governors University, share her perspectives on the importance of leadership coming from the top, beginning with the role and composition of the board of trustees, on down into how organizations view their organization, and whether it's viewed a people business or a set of operations.…